BLP acted for Medtronic on the sale of its patient care division and other assets in Costa Rica.
Medtronic is one of the world’s largest standalone medical technology development companies. It is headquartered in Dublin, Ireland and operates in more than 140 countries.
With this transaction, valued at over $100 million, Medtronic will transfer its manufacturing facility of vascular products in Costa Rica to Cardinal Health. This Costa Rica deal is part of Cardinal Health´s acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business, valued globally at $6.1 billion.
Cardinal Health is a healthcare services and products multinational headquartered in Dublin, Ohio.
Goldman Sachs and Perella Weinberg Partners served as Cardinal Health’s financial advisors on this transaction. The company instructed Skadden, Arps, Slate, Meagher & Flom and Jones Day as legal counsel.
Partner Ronald Lachner led the BLP team advising Medtronic in Costa Rica.